Total Funding
57
52
Total FundingGrant raised
Growth Score 57 in past quarter
-3 pts
Heat Score 52 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
51127
DiamiR is a leading molecular diagnostics company.
- Samuil Umansky: Co-founder, President & CSO
- Past Role: Interpace Biosciences, Chief Development Officer
Aptorum Group
About the Company
DiamiR is mission is to build a leading molecular diagnostics company focused on developing minimally invasive solutions for early detection and monitoring of brain and synaptic health conditions, including mild cognitive impairment and Alzheimer’s disease, to enable earlier intervention and better planning of care.
Women Founded
Women Led